Compare BIAF & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIAF | SGLY |
|---|---|---|
| Founded | 2014 | 2001 |
| Country | United States | United States |
| Employees | 57 | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 5.3M |
| IPO Year | N/A | 2008 |
| Metric | BIAF | SGLY |
|---|---|---|
| Price | $1.04 | $0.40 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 226.3K | 57.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 48.29 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,813,193.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.04 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.16 | $0.34 |
| 52 Week High | $13.50 | $1.86 |
| Indicator | BIAF | SGLY |
|---|---|---|
| Relative Strength Index (RSI) | 47.36 | 42.80 |
| Support Level | $0.90 | $0.34 |
| Resistance Level | $1.45 | $0.43 |
| Average True Range (ATR) | 0.12 | 0.03 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 28.57 | 66.89 |
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.